Bioactive Products
A unique collection of 71 Immunomodulators natural compounds for high throughput screening (HTS) | ||
Catalog No: | Bb172 | Immunomodulators Compound Library Screening Details |
Size: | 1mg/well * 71 Compounds 2mg/well * 71 Compounds |
Cat. No. | Information |
CFN98787 | Auraptene Auraptene possesses anticarcinogenic, cardioprotective, anti-inflammatory, anti-oxidant, antihelicobacter, antigenotoxic, and neuroprotective effects. Auraptene has a potential to attenuate chronic inflammation in adipose tissue and to improve obesity-related insulin resistance, and has protective effects in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. |
CFN98804 | Friedelanol Friedelanol and baccharis oxide may display an immunomodulatory action, they can increase reactive oxygen intermediate (H2O2) production by macrophages at a concentration of 100 uM. |
CFN98815 | Plumieride Plumieride has plant growth inhibiting properties, it shows strong fungitoxicity against some dermatophytes causing dermatomycosis to animals and human beings. Plumieride also has antioxidant , and immunomodulatory activities. |
CFN98846 | Bilobetin Bilobetin treatment ameliorates hyperlipidaemia, lipotoxicity and insulin resistance in rats by stimulating PPARα-mediated lipid catabolism. |
CFN98867 | Kirenol Kirenol possesses anti-bacteria, immunosuppression, anti-obesity, anti-oxidant, anti-inflammatory, anti-allergic, and anti-arthritic activities. Kirenol has significant potential for its discovery as a new lead compound for management of topical pain and inflammation; it can upregulate nuclear Annexin-1 which interacts with NF-κB to attenuate synovial inflammation of collagen-induced arthritis in rats. Kirenol can attenuate experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells. Kirenol activates the BMP and Wnt/β-catenin signaling pathways. |